Recurrent episode of very late stent thrombosis in a patient who underwent percutaneous coronary intervention with sirolimus-eluting stent: Same or different mechanism?
作者信息
Suh Soon Yong, Kang Woong Chol, Ahn Taehoon
机构信息
Cardiology Division, Department of Internal Medicine, Heart Center, Gil Hospital, Gachon University, 1198 Kuwol-dong, Namdong-gu, Incheon 405-760, Republic of Korea.
出版信息
J Cardiol Cases. 2011 Dec 6;5(1):e8-e11. doi: 10.1016/j.jccase.2011.10.007. eCollection 2012 Feb.
Abstract
We describe a case of a young patient with a recurrent episode of very late stent thrombosis (VLST) in whom the sirolimus-eluting stent was implanted on the culprit lesion in the left anterior descending artery. The present case showed when the etiology of VLST was not clear or in doubt of stent fracture, vigorous investigation for other causes using high resolution technology such as intravascular ultrasound or computed tomography angiography might be helpful for prevention of catastrophic events such as VLST.
摘要
相似文献
1
Recurrent episode of very late stent thrombosis in a patient who underwent percutaneous coronary intervention with sirolimus-eluting stent: Same or different mechanism?
J Cardiol Cases. 2011 Dec 6;5(1):e8-e11. doi: 10.1016/j.jccase.2011.10.007. eCollection 2012 Feb.
2
Serial intravascular ultrasound assessment of very late stent thrombosis after sirolimus-eluting stent placement.
J Cardiol. 2014 Oct;64(4):279-84. doi: 10.1016/j.jjcc.2014.02.008. Epub 2014 Mar 24.
3
Very late thrombosis after subintimal sirolimus-eluting stent implantation during percutaneous coronary intervention for chronic total occlusion.
J Invasive Cardiol. 2010 Aug;22(8):E162-5.
4
Efficacy of Endeavor zotarolimus-eluting stent implantation for the treatment of very late stent thrombosis with late-acquired incomplete stent apposition after sirolimus-eluting stent implantation.
Heart Vessels. 2016 Jul;31(7):1196-9. doi: 10.1007/s00380-015-0720-y. Epub 2015 Jul 29.
5
Comparisons of baseline demographics, clinical presentation, and long-term outcome among patients with early, late, and very late stent thrombosis of sirolimus-eluting stents: Observations from the Registry of Stent Thrombosis for Review and Reevaluation (RESTART).
Circulation. 2010 Jul 6;122(1):52-61. doi: 10.1161/CIRCULATIONAHA.109.903955. Epub 2010 Jun 21.
6
First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
JACC Cardiovasc Interv. 2013 Oct;6(10):1026-34. doi: 10.1016/j.jcin.2013.05.013. Epub 2013 Sep 18.
7
Characteristics of Earlier Versus Delayed Presentation of Very Late Drug-Eluting Stent Thrombosis: An Optical Coherence Tomographic Study.
J Am Heart Assoc. 2017 Apr 14;6(4):e005386. doi: 10.1161/JAHA.116.005386.
8
Late adverse events after implantation of sirolimus-eluting stent and bare-metal stent: long-term (5-7 years) follow-up of the Coronary Revascularization Demonstrating Outcome study-Kyoto registry Cohort-2.
Circ Cardiovasc Interv. 2014 Apr;7(2):168-79. doi: 10.1161/CIRCINTERVENTIONS.113.000987. Epub 2014 Feb 18.
9
Very Late Stent Thrombosis Due to Neoatherosclerosis After Implantation of an Ultra-Thin Strut Stent.
JACC Case Rep. 2023 Nov 9;28:102121. doi: 10.1016/j.jaccas.2023.102121. eCollection 2023 Dec 20.
10
Late thrombosis of sirolimus-eluting stent: a multifactorial problem.
Case Rep Med. 2009;2009:816715. doi: 10.1155/2009/816715. Epub 2009 Nov 4.
本文引用的文献
1
Multiple sequential complications after sirolimus-eluting stent implantation: very late stent thrombosis, stent fracture, in-stent restenosis, and peri-stent aneurysm.
Korean Circ J. 2009 Oct;39(10):439-42. doi: 10.4070/kcj.2009.39.10.439. Epub 2009 Oct 28.
2
Clinical and angiographic outcomes with sirolimus-eluting stents in total coronary occlusions: the ACROSS/TOSCA-4 (Approaches to Chronic Occlusions With Sirolimus-Eluting Stents/Total Occlusion Study of Coronary Arteries-4) trial.
JACC Cardiovasc Interv. 2009 Feb;2(2):97-106. doi: 10.1016/j.jcin.2008.10.013.
3
Detection of stent fractures: a comparison of 64-slice CT, conventional cine-angiography, and intravascular ultrasonography.
Acad Radiol. 2009 Apr;16(4):412-7. doi: 10.1016/j.acra.2008.10.010.
4
Classification and potential mechanisms of intravascular ultrasound patterns of stent fracture.
Am J Cardiol. 2009 Mar 15;103(6):818-23. doi: 10.1016/j.amjcard.2008.11.051.
5
Stent fracture: a biomaterial scientist's responsibility or an interventionist's onus?
Indian Heart J. 2007 Jan-Feb;59(1):5-8.
6
Drug-eluting stent thrombosis: results from the multicenter Spanish registry ESTROFA (Estudio ESpañol sobre TROmbosis de stents FArmacoactivos).
J Am Coll Cardiol. 2008 Mar 11;51(10):986-90. doi: 10.1016/j.jacc.2007.10.057.
7
Serial angiographic and intravascular ultrasound analysis of late stent strut fracture of sirolimus-eluting stents in native coronary arteries.
Int J Cardiol. 2008 Nov 12;130(2):255-9. doi: 10.1016/j.ijcard.2007.08.082. Epub 2007 Dec 21.
8
Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation.
Circulation. 2007 May 8;115(18):2426-34. doi: 10.1161/CIRCULATIONAHA.106.658237.
9
Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents.
Circulation. 2006 Feb 28;113(8):1108-13. doi: 10.1161/CIRCULATIONAHA.105.600155. Epub 2006 Feb 20.
10
Sirolimus-eluting stent fracture with thrombus, visualization by optical coherence tomography.
Eur Heart J. 2006 Jun;27(12):1389. doi: 10.1093/eurheartj/ehi542. Epub 2005 Oct 24.
Zotero 插件